These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 20810500)

  • 1. The LupusQoL and associations with demographics and clinical measurements in patients with systemic lupus erythematosus.
    McElhone K; Castelino M; Abbott J; Bruce IN; Ahmad Y; Shelmerdine J; Peers K; Isenberg D; Ferenkeh-Koroma A; Griffiths B; Akil M; Maddison P; Gordon C; Teh LS
    J Rheumatol; 2010 Nov; 37(11):2273-9. PubMed ID: 20810500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there an advantage over SF-36 with a quality of life measure that is specific to systemic lupus erythematosus?
    Touma Z; Gladman DD; Ibañez D; Urowitz MB
    J Rheumatol; 2011 Sep; 38(9):1898-905. PubMed ID: 21724700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study.
    Mok CC; Ho LY; Cheung MY; Yu KL; To CH
    Scand J Rheumatol; 2009; 38(2):121-7. PubMed ID: 18991189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus.
    McElhone K; Abbott J; Shelmerdine J; Bruce IN; Ahmad Y; Gordon C; Peers K; Isenberg D; Ferenkeh-Koroma A; Griffiths B; Akil M; Maddison P; Teh LS
    Arthritis Rheum; 2007 Aug; 57(6):972-9. PubMed ID: 17665467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Rheumatology Attitudes Index and its helplessness subscale are valid and reliable measures of learned helplessness in Asian patients with systemic lupus erythematosus.
    Thumboo J; Fong KY; Chan SP; Leong KH; Feng PH; Thio ST; Boey ML
    J Rheumatol; 1999 Jul; 26(7):1512-7. PubMed ID: 10405938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An exploration of patient-reported symptoms in systemic lupus erythematosus and the relationship to health-related quality of life.
    Pettersson S; Lövgren M; Eriksson LE; Moberg C; Svenungsson E; Gunnarsson I; Welin Henriksson E
    Scand J Rheumatol; 2012 Oct; 41(5):383-90. PubMed ID: 22646821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health related quality of life in Mexican women with systemic lupus erythematosus: a descriptive study using SF-36 and LupusQoL(C).
    García-Carrasco M; Mendoza-Pinto C; Cardiel MH; Méndez-Martínez S; García-Villaseñor A; Jiménez-Hernández C; Alonso-García NE; Briones-Rojas R; Ramos-Álvarez G; López-Colombo A
    Lupus; 2012 Oct; 21(11):1219-24. PubMed ID: 22875651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus.
    Stoll T; Gordon C; Seifert B; Richardson K; Malik J; Bacon PA; Isenberg DA
    J Rheumatol; 1997 Aug; 24(8):1608-14. PubMed ID: 9263159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of a disease-specific health-related quality of life measure in adult Italian patients with systemic lupus erythematosus: LupusQoL-IT.
    Conti F; Perricone C; Reboldi G; Gawlicki M; Bartosiewicz I; Pacucci VA; Massaro L; Miranda F; Truglia S; Alessandri C; Spinelli FR; Teh LS; Ceccarelli F; Valesini G
    Lupus; 2014 Jul; 23(8):743-51. PubMed ID: 24569393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity.
    Neville C; Clarke AE; Joseph L; Belisle P; Ferland D; Fortin PR
    J Rheumatol; 2000 Mar; 27(3):675-9. PubMed ID: 10743807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life assessed by LupusQoL questionnaire and SF-36 in Turkish patients with systemic lupus erythematosus.
    Yilmaz-Oner S; Oner C; Dogukan FM; Moses TF; Demir K; Tekayev N; Atagunduz P; Tuglular S; Direskeneli H
    Clin Rheumatol; 2016 Mar; 35(3):617-22. PubMed ID: 25846834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LupusQoL-FR is valid to assess quality of life in patients with systemic lupus erythematosus.
    Devilliers H; Amoura Z; Besancenot JF; Bonnotte B; Pasquali JL; Wahl D; Maurier F; Kaminsky P; Pennaforte JL; Magy-Bertrand N; Arnaud L; Binquet C; Guillemin F
    Rheumatology (Oxford); 2012 Oct; 51(10):1906-15. PubMed ID: 22826305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity and reliability of the Lupus QoL index in Turkish systemic lupus erythematosus patients.
    Pamuk ON; Onat AM; Donmez S; Mengüs C; Kisacik B
    Lupus; 2015 Jul; 24(8):816-21. PubMed ID: 25542903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life in portuguese SLE patients: an outcome measure independent of disease activity and cumulative damage.
    Duarte C; Abreu P; Couto M; Vaz C; Malcata A; Inês L
    Acta Reumatol Port; 2010; 35(1):30-5. PubMed ID: 20518146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associates of health status in patients with systemic lupus erythematosus.
    Sutcliffe N; Clarke AE; Levinton C; Frost C; Gordon C; Isenberg DA
    J Rheumatol; 1999 Nov; 26(11):2352-6. PubMed ID: 10555890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome measures to be used in clinical trials in systemic lupus erythematosus.
    Strand V; Gladman D; Isenberg D; Petri M; Smolen J; Tugwell P
    J Rheumatol; 1999 Feb; 26(2):490-7. PubMed ID: 9972993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construct and criterion validity of the short form-6D utility measure in patients with systemic lupus erythematosus.
    Harrison MJ; Ahmad Y; Haque S; Dale N; Teh LS; Snowden N; Ho P; Gorodkin R; Bruce IN
    J Rheumatol; 2012 Apr; 39(4):735-42. PubMed ID: 22298908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibromyalgia is a major contributor to quality of life in lupus.
    Gladman DD; Urowitz MB; Gough J; MacKinnon A
    J Rheumatol; 1997 Nov; 24(11):2145-8. PubMed ID: 9375874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired health status and the effect of pain and fatigue on functioning in clinical trial patients with systemic lupus erythematosus.
    Petri M; Kawata AK; Fernandes AW; Gajria K; Greth W; Hareendran A; Ethgen D
    J Rheumatol; 2013 Nov; 40(11):1865-74. PubMed ID: 24085548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome of early neuropsychiatric events due to active disease in systemic lupus erythematosus.
    Wang M; Gladman DD; Ibañez D; Urowitz MB
    Arthritis Care Res (Hoboken); 2012 Jun; 64(6):833-7. PubMed ID: 22290935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.